関連する実験動画
Updated: Sep 8, 2025
10:09
Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence
Published on: January 7, 2019
8.4K
クプロプトーシス関連遺伝子FDX1は,トリプルネガティブな乳がんの悪性進行と免疫抑制を誘導する
Haohang Sun1, Qi Chen1, Xiwei Zhang1
1Department of General Surgery, Zhenhai District People's Hospital, No. 718, South 2nd West Road, Camel Street, Zhenhai District, Ningbo City, 315200, Zhejiang, China.
Biochemical genetics
|September 5, 2025
まとめ
トリプルネガティブ乳がん (TNBC) は,クプロプトーシスに関連したFDX1の発現が増加しています. FDX1を阻害することで,腫瘍の成長が抑制され,T細胞の反応が改善された.
科学分野:
- 分子腫瘍学
- 癌 細胞 の 死 の 仕組み
- 免疫療法
背景:
- トリプルネガティブ乳がん (TNBC) は,治療の選択肢が限られている攻撃的なサブタイプです.
- 新しい細胞死経路であるクプロプトーシスと その鍵となる遺伝子FDX1は 癌に関与しています
- TNBCの異質性と免疫回避を理解することは,治療開発にとって極めて重要です.
研究 の 目的:
- TNBCにおけるFDX1とクプロプトーシスの役割を調査する.
- TNBCの上皮細胞におけるFDX1発現を分析する.
- TNBCの成長と腫瘍の免疫マイクロ環境に対するFDX1の影響を評価する.
主な方法:
- 乳がんサブタイプの単細胞RNA配列解析 (scRNA-seq)
- TNBC細胞系におけるFDX1のインビトロノックダウン.
- 細胞増殖,侵入,移動,T細胞共同培養の測定値の評価
- マウスモデルと免疫ヒストケミストリー (IHC) を用いたin vivo研究.
主要な成果:
- TNBCは,他のBC亜型と比較して,より高い上皮細胞の豊富さと,より低いT細胞の浸透を示しています.
- カプロプトーシスに関連したFDX1+上皮細胞は,TNBCで濃縮され,腫瘍の成長,侵入,移動を促します.
- FDX1のノックダウンにより,マウスの腫瘍の成長が抑制され,CD8+T細胞の活性化と細胞毒性が調節された.
- FDX1は,CD8+ T細胞によって媒介される抗腫瘍免疫反応を抑制する.
結論:
- FDX1はTNBCの進行と免疫回避の重要な原動力です.
- FDX1を標的とした治療は,TNBCの新たな治療戦略である可能性があります.
- FDX1を調節すると,TNBCの文脈で抗腫瘍免疫が強化される可能性があります.
関連する概念動画
02:23Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
02:07Tumor Progression
6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K
03:03mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
01:12Loss of Tumor Suppressor Gene Functions
5.1K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
5.1K
01:24Regulation of Angiogenesis and Blood Supply
2.7K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.7K